These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 18698541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP, Wei CP, Ma SC, Zhang YF, Qiao LY, Li DH, Shan RB.
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F.
    Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol reduces elevated B-type natriuretic peptide in dialyzed patients without heart failure: cardioprotective effect of the beta-blocker.
    Kojima M, Sato K, Kimura G, Ueda R, Dohi Y.
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):191-6. PubMed ID: 17438403
    [Abstract] [Full Text] [Related]

  • 10. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A, Andersson B, Edner M, Nylander E, Persson H, Dahlström U.
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [Abstract] [Full Text] [Related]

  • 11. Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.
    Frantz RP, Olson LJ, Grill D, Moualla SK, Nelson SM, Nobrega TP, Hanna RD, Backes RJ, Mookadam F, Heublein D, Bailey KR, Burnett JC.
    Am Heart J; 2005 Mar; 149(3):541-7. PubMed ID: 15864245
    [Abstract] [Full Text] [Related]

  • 12. Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol.
    Jourdain P, Funck F, Fulla Y, Hagege A, Bellorini M, Guillard N, Loiret J, Thebault B, Desnos M.
    Eur J Heart Fail; 2002 Jun; 4(3):269-76. PubMed ID: 12034151
    [Abstract] [Full Text] [Related]

  • 13. Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure.
    Susa T, Kobayashi S, Tanaka T, Murakami W, Akashi S, Kunitsugu I, Okuda S, Doi M, Wada Y, Nao T, Yamada J, Ueyama T, Okamura T, Yano M, Matsuzaki M.
    Circ J; 2012 Jun; 76(1):117-26. PubMed ID: 22008315
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of beta-blocker (carvedilol) therapy on N-terminal pro-brain natriuretic peptide levels and echocardiographic findings in patients with congestive heart failure.
    Gundogdu F, Bozkurt E, Kiziltunc A, Sevimli S, Arslan S, Gurlertop Y, Senocak H, Karakelleoglu S.
    Echocardiography; 2007 Feb; 24(2):113-7. PubMed ID: 17313541
    [Abstract] [Full Text] [Related]

  • 16. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.
    Richards AM, Doughty R, Nicholls MG, MacMahon S, Sharpe N, Murphy J, Espiner EA, Frampton C, Yandle TG, Australia-New Zealand Heart Failure Group.
    J Am Coll Cardiol; 2001 Jun 01; 37(7):1781-7. PubMed ID: 11401111
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
    Khand AU, Chew PG, Douglas H, Jones J, Jan A, Cleland JG.
    Cardiology; 2015 Jun 01; 130(3):153-8. PubMed ID: 25660493
    [Abstract] [Full Text] [Related]

  • 19. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment.
    Kawai K, Hata K, Takaoka H, Kawai H, Yokoyama M.
    Am Heart J; 2001 Jun 01; 141(6):925-32. PubMed ID: 11376305
    [Abstract] [Full Text] [Related]

  • 20. Restrictive filling pattern predicts pulmonary hypertension and is associated with increased BNP levels and impaired exercise capacity in patients with heart failure.
    Straburzyńska-Migaj E, Szyszka A, Trojnarska O, Cieśliński A.
    Kardiol Pol; 2007 Sep 01; 65(9):1049-55; discussion 1056-7. PubMed ID: 17975752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.